| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | Feb 22, 2024 | Voyager Therapeutics, Inc. | CFO | Sell | 46.3 | -3,764 | -2.10% | ✗ | $28.1K |
| Oct 3, 2023 | Oct 5, 2023 | Voyager Therapeutics, Inc. | CFO | Sell | 42.5 | -13,567 | -8.32% | ✗ | $94.8K |
| Feb 18, 2022 | Feb 23, 2022 | Korro Bio, Inc. | CFO | Sell | 46.3 | -2,946 | -24.81% | ✗ | $10.9K |
| Feb 16, 2022 | Feb 18, 2022 | Korro Bio, Inc. | CFO | Sell | 46.3 | -2,525 | -17.54% | ✗ | $10.9K |
| Feb 14, 2022 | Feb 16, 2022 | Korro Bio, Inc. | CFO | Sell | 47.5 | -1,347 | -8.56% | ✗ | $5.8K |
| Oct 15, 2020 | Oct 16, 2020 | UroGen Pharma Ltd. | CFO | Sell | 42.5 | -2,400 | -18.74% | ✗ | $52.2K |
| Sep 1, 2020 | Sep 1, 2020 | UroGen Pharma Ltd. | CFO | Sell | 46.3 | -509 | -6.06% | ✗ | $11.6K |
| Jul 26, 2020 | Jul 28, 2020 | UroGen Pharma Ltd. | CFO | Sell | 47.5 | -141 | -1.88% | ✗ | $3.3K |
| May 20, 2020 | May 20, 2020 | UroGen Pharma Ltd. | CFO | Sell | 47.5 | -358 | -4.81% | ✗ | $9K |
| Apr 26, 2020 | Apr 28, 2020 | UroGen Pharma Ltd. | CFO | Sell | 47.5 | -141 | -2.16% | ✗ | $3.4K |
| Feb 20, 2020 | Feb 24, 2020 | UroGen Pharma Ltd. | CFO | Sell | 46.3 | -360 | -5.56% | ✗ | $10.7K |
| Jan 26, 2020 | Jan 28, 2020 | UroGen Pharma Ltd. | CFO | Sell | 46.3 | -667 | -13.07% | ✗ | $19.5K |
| Nov 20, 2019 | Nov 22, 2019 | UroGen Pharma Ltd. | CFO | Sell | 46.3 | -354 | -9.33% | ✗ | $10.1K |
| Aug 20, 2019 | Aug 22, 2019 | UroGen Pharma Ltd. | CFO | Sell | 46.3 | -1,416 | -33.98% | ✗ | $46.8K |